Pharmacological characterization of 5-Hydroxytryptamine-receptor subtypes in circular muscle from the rat stomach

Biol Pharm Bull. 2007 Mar;30(3):508-13. doi: 10.1248/bpb.30.508.

Abstract

5-Hydroxytryptamine (5-HT) modulates gastric motility and gastric emptying via a variety of 5-HT receptor subtypes. However, regional and functional differences among 5-HT receptor subtypes in the rat stomach are not fully investigated. Thus, we aimed to characterize 5-HT receptor subtypes involved in the 5-HT-induced contractions in the isolated antral, corporal and fundic circular muscles of the rat stomach by measuring the contractile force. 5-HT induced concentration-dependent contractions in the antrum, corpus and fundus. 5-HT-induced antral contractions were partly blocked by atropine and enhanced by tetrodotoxin (TTX). Neither atropine nor TTX affected the corporal or the fundic contractions to 5-HT. In the antrum, 5-HT-induced contractions were inhibited by methysergide, tended to be inhibited by ketanserin, enhanced by SB-203186, but were not affected by WAY-100635, GR127935, RS-127445, ondansetron, or SB-269970. In the corpus, 5-HT-induced contractions were inhibited by ketanserin or methysergide. In the fundus, 5-HT-induced contractions were blocked by methysergide or RS-127445, but were enhanced by cinanserin or SB-203186. It is thus concluded that contractile responses to 5-HT in the antrum are mediated by 5-HT receptors on both smooth muscle and neurons whilst in the corpus and fundus responses are mainly mediated by 5-HT receptors on smooth muscle. Moreover, the antrum presents the contractile 5-HT2A and 5-HT2B receptors and the relaxant 5-HT4 receptors. The corpus presents the contractile 5-HT2A receptors, and the fundus presents the contractile 5-HT2B receptors and the relaxant 5-HT2A and 5-HT4 receptors.

MeSH terms

  • Animals
  • Atropine / pharmacology
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Gastric Emptying / drug effects
  • Gastric Emptying / physiology
  • Gastric Fundus / drug effects
  • Gastric Fundus / physiology
  • In Vitro Techniques
  • Indoles / pharmacology
  • Ketanserin / pharmacology
  • Methysergide / pharmacology
  • Muscle Contraction / drug effects
  • Muscle Contraction / physiology*
  • Muscle, Smooth / drug effects
  • Muscle, Smooth / physiology*
  • Ondansetron / pharmacology
  • Oxadiazoles / pharmacology
  • Phenols / pharmacology
  • Piperazines / pharmacology
  • Piperidines / pharmacology
  • Protein Isoforms / physiology
  • Pyloric Antrum / drug effects
  • Pyloric Antrum / physiology
  • Pyridines / pharmacology
  • Pyrimidines / pharmacology
  • Rats
  • Receptors, Serotonin / physiology*
  • Serotonin / pharmacology
  • Serotonin Antagonists / pharmacology
  • Stomach / drug effects
  • Stomach / physiology*
  • Sulfonamides / pharmacology
  • Tetrodotoxin / pharmacology

Substances

  • (1-piperidinyl)ethyl 1H-indole-3-carboxylate
  • Indoles
  • Oxadiazoles
  • Phenols
  • Piperazines
  • Piperidines
  • Protein Isoforms
  • Pyridines
  • Pyrimidines
  • Receptors, Serotonin
  • SB 269970
  • Serotonin Antagonists
  • Sulfonamides
  • 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine
  • GR 127935
  • Serotonin
  • Tetrodotoxin
  • Ondansetron
  • N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide
  • Atropine
  • Ketanserin
  • Methysergide